Sign in
4

Changes in Ownership

Fulcrum Therapeutics, Inc. Filed Acc 0000899243-22-021530

Director sold 71,435 shares at $8.09 ($577,895)

  • Director acquired 71,435 shares (option exercise)

From the SEC's structured data for this filing

Trades in this filing

Gould Robert J · Director

Table I: Non-derivative

2 lines
Date Transaction Shares Price Value Owned after D/I
2022-06-07 Exercise or conversion : show line 1 in the form +71,435 $7.84 $560,050 578,065 D
2022-06-07 Sale : show line 2 in the form −71,435 $8.09 $577,895 506,630 D
Open-market sales · 71,435 sh · avg $8.09 · $577,895

Table II: Derivative

1 line
Date Transaction Shares Owned after D/I
2022-06-07 Exercise or conversion : show line 3 in the form Stock Option (right to buy) −71,435 86,523 D
Loading xslF345X03/doc4.xml…